Previous studies showed that oncolytic viruses can reprogram the tumor microenvironment and increase the infiltration of immune cells; indeed, T-VEC can reprogram immune-silent tumors into immune-inflamed tumors and induce the expression of PD1 and PDL1. Here, CD274 is linked to neoplasm.